Adhesion and entry of uropathogenic Escherichia coli

Cellular Microbiology

Volumn 4, Issue 5, 2002, Pages 257-271

  Mulvey, Matthew A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN;

ANIMAL CELL; ANIMAL TISSUE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BACTERIUM DETECTION; CELL ADHESION; CELL INVASION; CELL ORGANELLE; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; FIMBRIA; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RAT; SHORT SURVEY; URINARY TRACT; URINARY TRACT INFECTION; UROTHELIUM;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0036258843     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1462-5822.2002.00193.x     Document Type: Short Survey

References (140)

1. Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract
2. Biogenesis of E. coli Pap pili: PapH, a minor pilin subunit involved in cell anchoring and length modulation
3. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic
4. A key role for type 1 pili in enterobacterial communicability
5. The regulation of pap and type 1 fimbriation in Escherichia coli
6. Non-flagellar appendages of bacteria
7. Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili
8. Structural polymorphism of bacterial adhesion pili
9. X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli [see comments]
10. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract
11. Cell biology of caveolae and caveolin
12. Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor
13. Internalization of Escherichia coli into human kidney epithelial cells: Comparison of fecal and pyelonephritis-associated strains
14. Bacteriology and ultrastructure of the bladder in patients with urinary tract infections
15. Distribution of papG alleles among uropathogenic Escherichia coli isolated from different species
16. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection
17. Urinary tract infection: Self-reported incidence and associated costs
18. Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis
19. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation
20. An electron microscopic study of the interaction between vesical epitherlium and E. Coli
21. Pathogenetic aspects of uncomplicated urinary tract infection: Recent advances
22. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri
23. Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration
24. Role of fimbriae-mediated adherence for neutrophil migration across Escherichia coli-infected epithelial cell layers
25. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection
26. Binding of pili from uropathogenic Escherichia coli to membranes secreted by human colonocytes and enterocytes
27. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line
28. Development of experimental model of chronic pyelonephritis with Escherichia coli O75: K5: H-bearing Dr fimbriae: Mutation in the dra region prevented tubulointerstitial nephritis
29. Decay-accelerating factor and cytoskeleton redistribution pattern in HeLa cells infected with recombinant Escherichia coli strains expressing Dr family of adhesins
30. Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis
31. Nuclear magnetic resonance and conformational investigations of the pentasaccharide of the Forssman antigen and overlapping di-, tri-, and tetra-saccharide sequences
32. Recruitment of CD55 and CD66e brush border-associated glycosylphosphatidylinositol-anchored proteins by members of the Afa/Dr diffusely adhering family of Escherichia coli that infect the human polarized intestinal Caco-2/TC7 cells
33. Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: Evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway and dynamic unstable microtubules
34. Cloning and characterization of the S fimbrial adhesin II complex of an Escherichia coli O18: K1 meningitis isolate
35. Pathogenicity islands and the evolution of microbes
36. Genetic characterization of Escherichia coli type 1 pilus adhesin mutants and identification of a novel binding phenotype
37. Host and bacterial factors involved in the innate ability of mouse macrophages to eliminate internalized unopsonized Escherichia coli
38. Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract
39. Specificity of S fimbriae on recombinant Escherichia coli: Preferential binding to gangliosides expressing NeuGc alpha (2-3) Gal and NeuAc alpha (2-8) NeuAc
40. Neutrophil Recruitment and Resistance to Urinary Tract Infection
41. Characterization of Escherichia coli type 1 pilus mutants with altered binding specificities
42. P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses [In Process Citation]
43. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells
44. Molecular switches - The ON and OFF of bacterial phase variation
45. PapB paralogues and their effect on the phase variation of type 1 fimbriae in Escherichia coli
46. Diagnosis and treatment of uncomplicated urinary tract infection
47. Adherence of uropathogenic E. coli to differentiated human uroepithelial cells grown in vitro
48. Bacterial Adhesins and Their Assembly
49. Pilus biogenesis via the chaperone/usher pathway: An integration of structure and function
50. Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili
51. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection
52. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies
53. Initiation of assembly and association of the structural elements of a bacterial pilus depend on two specialized tip proteins
54. Predominance of class II papG allele of Escherichia coli in pyelonephritis in infants with normal urinary tract anatomy
55. Virulence factors in Escherichia coli urinary tract infection
56. Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice
57. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae
58. Cell cycle of normal bladder urothelium in developing and adult mice
59. Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively
60. Receptor structure for F1C fimbriae of uropathogenic Escherichia coli
61. Reciprocal exchange of minor components of Type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities
62. Uropathogenic Escherichia coli Potentiates Type 1 Pilus-Induced Apoptosis by Suppressing NF-kappaB
63. Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis
64. Binding of Escherichia coli S fimbriae to human kidney epithelium
65. P pili in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips
66. Basement membrane carbohydrate as a target for bacterial adhesion: Binding of type 1 fimbriae of Salmonella enterica and Escherichia coli to laminin
67. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination
68. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes
69. Internalization of FimH+ Escherichia coli by the human mast cell line (HMC-1 5C6) involves protein kinase C
70. Fimbriae
71. The PapG protein is the alpha-D-galactopyranosyl-(1-4) - Beta-D-galactopyranose-binding adhesin of uropathogenic Escherichia coli
72. Role of intestinal surfactant-like particles as a potential reservoir of uropathogenic Escherichia coli
73. Terminal glycosylation of bovine uroplakin III, one of the major integral-membrane glycoproteins of mammalian bladder
74. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group
75. Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model
76. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells
77. Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli
78. What makes microbes stick?
79. The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis
80. Isolation and characterization of the a-sialyl-b-2,3-galactosyl-specific adhesin from fimbrilated Escherichia coli
81. Functional analysis of the sialic acid-binding adhesin SfaS of pathogenic Escherichia coli by site-specific mutagenesis
82. Regulation and binding properties of S fimbriae cloned from E. coli strains causing urinary tract infection and meningitis
83. Escherichia coli in Urinary Tract Infections
84. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli
85. Cell biology. Bacterial spelunkers
86. Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defenses
87. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection
88. Molecular Regulation of Urothelial Renewal and Host Defenses during Infection with Uropathogenic Escherichia coli
89. Family of Escherichia coli Dr adhesins: Decay-accelerating factor receptor recognition and invasiveness
90. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice: Gal-Gal pili immunization prevents Escherichia coli pyelonephritis
91. Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors
92. Gene clusters for S fimbrial adhesin (sfa) and F1C fimbriae (foc) of Escherichia coli: Comparative aspects structure function
93. Adhesion of type 1-fimbriated Escherichia coli to abiotic surfaces leads to altered composition of outer membrane proteins
94. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin la and lb receptors
95. Internalization of Escherichia coli by human renal epithelial cells is associated with tyrosine phosphorylation of specific host cell proteins
96. Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis
97. Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis
98. Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells
99. Escherichia coli-induced inducible nitric oxide synthase and cyclooxygenase expression in the mouse bladder and kidney
100. Amino acid residue Ala-62 in the FimH fimbrial adhesin is critical for the adhesiveness of meningitis-associated Escherichia coli to collagens
101. Adhesion of S-fimbriated Escherichia coli to brain glycolipids mediated by sfaA gene encoded protein of S-fimbriae
102. Genetic analysis of Escherichia coli biofilm formation: Roles of flagella, motility, chemotaxis and type 1 pili
103. The Gal a (1-4) Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract
104. Lesions in two Escherichia coli type 1 pilus genes alter pilus number and length without affecting receptor binding
105. A yeast gene important for protein assembly into the endoplasmic reticulum and the nucleus has homology to DnaJ, an Escherichia coli heat shock protein
106. PapD-like chaperones and pilus biogenesis
107. Functional flexibility of the FimH adhesin: Insights from a random mutant library
108. FimH-mediated autoaggregation of Escherichia coli
109. Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence
110. Coordinate gene regulation by fimbriae-induced signal transduction
111. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism
112. Analysis of genes coding for the sialic acid-binding adhesin and two other minor fimbrial subunits of the S-fimbrial adhesin determinant of Escherichia coli
113. Osmolarity and pH Growth Conditions Regulate fim Gene Transcription and Type 1 Pilus Expression in Uropathogenic Escherichia coli
114. Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli
115. Involvement of cellular caveolae in bacterial entry into mast cells
116. Pathogenesis of urinary tract infection. Role of host defenses
117. FimH family of type 1 fimbrial adhesins: Functional heterogeneity due to minor sequence variations among fimH genes
118. Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes
119. Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells
120. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin
121. Valency conversion in the type 1 fimbrial adhesin of Escherichia coli
122. Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli
123. Type 1 fimbriate Escherichia coli stimulates a unique pattern of degranulation by human polymorphonuclear leukocytes
124. Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gala (1-4) Gal-containing isoreceptors
125. Saccharide orientation at the cell surface affects glycolipid receptor function
126. Formation of asymmetric unit membrane during urothelial differentiation
127. The solution structure of PapGII from uropathogenic Escherichia coli and its recognition of glycolipid receptors
128. Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection
129. Bacterial virulence in urinary tract infection
130. Bacterial adherence and mucosal cytokine responses. Receptors and transmembrane signaling
131. Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli
132. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection
133. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities
134. Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells
135. Internalization of Escherichia coli into human renal tubular epithelial cells
136. Epigenetic phase variation of the pap operon in Escherichia coli
137. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract
138. Regulatory cross-talk between adhesin operons in Escherichia coli: Inhibition of type 1 fimbriae expression by the PapB protein
139. Molecular epidemiologic approaches to urinary tract infection gene discovery in uropathogenic Escherichia coli
140. Uroplakin la is the urothelial receptor for uropathogenic Escherichia coli: Evidence from in vitro FimH binding